Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?
Paul Beinhoff(Medical College of Wisconsin), Marja T. Nevalainen(Thomas Jefferson University), Kenneth Jacobsohn(Medical College of Wisconsin), Peter S. LaViolette(Medical College of Wisconsin), Susan Tsai(The Ohio State University Wexner Medical Center), Vindhya Udhane(Medical College of Wisconsin), Deepak Kilari(Medical College of Wisconsin), Scott M. Dehm(University of Minnesota), Lavannya Sabharwal(Medical College of Wisconsin), Cristina Maranto(Istituto di Biomedicina e di Immunologia Molecolare Alberto Monroy), William A. Hall(Medical College of Wisconsin), Liang Wang(Fujian Women and Children Hospital), Kenneth A. Iczkowski(University of California, Davis)
Cited by 24
Related Papers
Characterization of human plasma-derived exosomal RNAs by deep sequencing
|BMC Genomics|2013|1.1k
Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia
|Neuron|2009|1k
Classification of renal cell carcinoma
|Cancer|1997|878
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705